Challenges in the Fight Against Yaws
Recent studies reveal setbacks in eliminating yaws, highlighting new treatment strategies.
Amber Barton, P. Pospisilova, C. G. Beiras, L. N. John, W. Houinei, L. Giacani, D. Smajs, M. Marks, O. Mitja, M. A. Beale, N. R. Thomson
― 5 min read
Table of Contents
- History of Treatment Efforts
- Challenges in Eliminating Yaws
- Recent Studies and Findings
- Study Population and Sample Collection
- Genetic Diversity of Yaws
- Geographic Patterns and Transmission
- Demographic Factors in Transmission
- Key Findings on Persistent Strains
- Implications for Future Treatment Strategies
- Conclusion
- Original Source
Yaws is a disease caused by a type of bacteria called Treponema pallidum subspecies pertenue. It mostly affects people in tropical areas, with the highest rates found in Papua New Guinea and the Solomon Islands. Many new cases are seen in children under 15 years old. Initially, the disease causes sores on the skin that can heal in a few months. However, if left untreated, it can lead to more serious problems like skin and bone issues, causing long-term health problems and disabilities.
If we don't work to eliminate yaws, it is estimated that millions of years of healthy life could be lost due to disability from this disease.
History of Treatment Efforts
Between the 1950s and 1960s, a major campaign led by the World Health Organization (WHO) and UNICEF successfully reduced yaws cases by 95%. This was achieved by treating people with a medicine called benzathine benzylpenicillin through injections. However, some challenges arose, especially in remote areas where getting the injections was difficult. There were also many cases of yaws that didn’t show symptoms, which made it hard to eliminate the disease completely.
In 2012, researchers found that a one-time treatment with oral Azithromycin was very effective against yaws, prompting the WHO to start a new strategy to eliminate the disease, involving mass drug administration in communities where yaws was common.
Challenges in Eliminating Yaws
From 2013 to 2016, a study on Lihir Island in Papua New Guinea showed that the new strategy only led to a temporary reduction in yaws cases. After a while, the number of cases went up again due to different strains of the bacteria. Also, some cases that were linked to a genetic change making them resistant to treatment were found.
Many patients missed the initial treatment, which showed that multiple rounds of medication might be necessary to break the chain of transmission.
Recent Studies and Findings
A major study was carried out from 2018 to 2019 involving over 56,000 individuals in a region called Namatanai in New Ireland, Papua New Guinea. This study compared two groups: one that followed the previous treatment approach with one round of mass drug administration followed by treatment of active cases, and another group that received three rounds of treatment.
After 18 months, the group that received three rounds saw a much larger drop in active cases than the control group. However, some cases of the resistant strain were still found.
The study on the genomes (the complete set of genes) of the bacteria showed that the diversity of the bacteria decreased after treatment. Persisting strains were still present in both groups of participants during the study.
Study Population and Sample Collection
Samples for analysis were collected from different local areas that were part of the study. The study had permission from the local health authorities, and participants provided oral consent for their involvement.
A large number of samples were collected, tested, and then analyzed to understand the genetic makeup of the bacteria. The results were used to create a detailed picture of the bacterial strains and how they spread within the community.
Genetic Diversity of Yaws
The analysis showed that T. pertenue bacteria from the Namatanai area were quite similar genetically. Researchers were able to classify the bacteria into different groups based on their genetic differences. Some strains were found to be resilient, continuing to exist and spread in the community despite several rounds of treatment.
Certain genetic variations in the bacteria were linked to differences in how long symptoms lasted and the level of antibodies present in infected individuals.
Geographic Patterns and Transmission
Despite thinking that the bacteria would be mixed throughout the studied area, the findings showed that certain strains were more likely to be found in specific local areas. This could be due to limited movement in these remote regions.
The clustering of cases in close geographic areas suggests that targeted treatment could be more effective, as stronger measures could be applied in areas with higher numbers of yaws cases.
Demographic Factors in Transmission
The research found that older children were more likely to share the same strains of the bacteria, suggesting that schools may play a role in how the disease spreads among young people. It was also discovered that sex did not appear to significantly influence transmission patterns.
Key Findings on Persistent Strains
Two specific strains of the bacteria managed to survive throughout the study and were found in individuals from both treatment groups. Those infected with one of these strains reported longer ulcer durations and lower levels of antibodies.
Certain genetic changes in the bacteria were linked to these traits, and these variants were potentially associated with the bacteria’s ability to avoid being recognized by the immune system.
Implications for Future Treatment Strategies
The findings of this study suggest that simply administering one round of treatment is not enough to eliminate yaws effectively. More rounds of treatment could help in keeping the number of cases down. However, this needs to be balanced with the costs involved in doing so.
The geographic clustering indicates that targeted interventions could be a feasible approach to reduce yaws cases significantly. It also suggests that initiatives in schools could be effective in breaking the cycle of transmission among children.
While the study was promising, it showed that there is still a risk for the bacteria to develop resistance, especially after repeated treatments, which poses a challenge for future campaigns aiming to eradicate yaws completely. Continuous monitoring and surveillance for resistant strains are necessary for the success of elimination efforts.
Conclusion
In conclusion, the fight against yaws remains complex, but the insights gained from recent studies can help shape future strategies and interventions. A combination of repeated treatment, targeted approaches, and monitoring for resistance will be key in moving closer to the goal of eradicating yaws and reducing its burden on affected populations.
Title: The Effect of Repeated Mass Drug Administration on the Transmission of Yaws: A Genomic Epidemiology Study
Abstract: BackgroundYaws, a neglected tropical disease caused by Treponema pallidum subspecies pertenue, has evaded eradication, in part due to a high proportion of asymptomatic cases. A cluster-randomised trial in a yaws endemic area compared repeated mass drug administration (MDA) with one round of MDA followed by targeted treatment. Repeated rounds of MDA reduced active and latent prevalence of yaws but led to emergence and spread of azithromycin resistance to three children. Here we aimed to finely delineate the dynamics of T. pertenue sub-lineages over the course of this trial. MethodsWe performed whole genome sequencing directly on DNA from 263 swabs collected during this trial, recovering 222 good-quality T. pertenue genomes. We examined the phylogenetic relationships between genomes linked to geospatial and patient metadata. FindingsWe identified 29 fine-scale sub-lineages of T. pertenue, of which ten were eliminated by MDA, whilst 13 persisted in the control arm, one in the experimental arm, two in both study arms, and three were first observed after commencing MDA. The two persistent sub-lineages had non-synonymous mutations in penicillin binding proteins. One of these sub-lineages evolved macrolide resistance (N=3), and was associated with lowered treponemal antibody levels (p = 0.004) and longer ulcer duration (p = 0.015). Despite the study taking place within a relatively small geographic area (Namatanai District, in the Island of New Ireland, Papua New Guinea) sub-lineages were geographically clustered, and older children were more likely to share sub-lineages (p = 6x10-9). InterpretationOur findings show that the re-emergence of yaws after MDA was attributed to multiple sub-lineages. The majority of these sub-lineages were detected in the population prior to MDA, and participants were more likely to share sub-lineages within the same ward, suggesting that re-emergence was mostly driven by local transmission. These findings could help inform future yaws elimination strategies. FundingEuropean Research Council, European Union, Provincial Deputation of Barcelona, Barbera Solidaria Foundation and Wellcome. Research in contextO_ST_ABSEvidence before this studyC_ST_ABSWe searched PubMed on 24th July 2024 using the terms treponema * pertenue OR yaws, genom* OR sequencing, and "mass drug administration" OR azithromycin OR "mass treatment", without restrictions for language or date. Two studies were previously published on the current cohort from the Namatanai Province, Papua New Guinea, comparing three rounds of mass drug administration (MDA) with one round of MDA followed by targeted treatment. These studies used multi-locus sequence-typing and found that repeated MDA limited yaws to one sequence-type but resulted in three cases of macrolide resistance. A separate study used whole genome sequencing to find that after a single round of MDA on Lihir Island, Papua New Guinea, a rebound in yaws cases was caused by multiple sub-lineages of the same MLST, but evolution of macrolide resistance only occurred once. No studies have yet examined how repeated MDA affects the whole-genome diversity and evolution of yaws. Added value of this studyOur findings show that re-emergence of yaws after MDA was caused by multiple sub-lineages, most of which were already present in the population before MDA. In the group undergoing three rounds of MDA there was still a small rebound in cases six months after the third round, caused by two "persistent" sub-lineages with mutations in penicillin-binding proteins. One of these sub-lineages was associated with lower treponemal antibody and developed macrolide resistance. Sub-lineages were more likely to be shared between older participants and those in close geographical proximity. Implications of all the available evidenceThese data suggest that re-emergence is predominantly driven by cases missed by the initial round of MDA rather than by importation of new cases. Much more efficient population suppression was achieved using three rounds of MDA, and this is likely due to more comprehensively treating the population and eliminating latent cases. Geographical clustering of sub-lineages suggests that elimination by maintaining cases at a low enough prevalence to result in stochastic "fade out" could be feasible and achieved by repeated mass drug administration. Transmission was found to be most common amongst older children, and targeted approaches focusing on these groups may be beneficial. However, ongoing surveillance for macrolide resistance will be needed to achieve eradication.
Authors: Amber Barton, P. Pospisilova, C. G. Beiras, L. N. John, W. Houinei, L. Giacani, D. Smajs, M. Marks, O. Mitja, M. A. Beale, N. R. Thomson
Last Update: 2024-10-27 00:00:00
Language: English
Source URL: https://www.medrxiv.org/content/10.1101/2024.10.27.24316187
Source PDF: https://www.medrxiv.org/content/10.1101/2024.10.27.24316187.full.pdf
Licence: https://creativecommons.org/licenses/by/4.0/
Changes: This summary was created with assistance from AI and may have inaccuracies. For accurate information, please refer to the original source documents linked here.
Thank you to medrxiv for use of its open access interoperability.